Breviscapine Liposome (CAT#: LDLY-1023-LD29)

Description
Breviscapine is a mixture of apigenin-7-O-β-D-glucuronide and scutellarin, which is widely used in cardiovascular and cerebrovascular diseases as it dilates cerebral blood vessels and resists platelet aggregation. This product is a PEGylated pre-formulated liposome with breviscapine. It is only for research purposes.
Lipid Composition
Egg PC, Cholesterol, DSPE-PEG(2000)
Encapsulated Drug
Breviscapine
Buffer
PBS, pH 7.0
Storage
Store in dark at +4°C and do not freeze
Size
100-500 nm
Quantity
5mL (available in lyophilized powder)
Dosage
Download
DataSheet MSDS
Customer Reviews Related Sections

Click the button below to contact us or submit your feedback about this product.

Products
Services
Applications
Technical Support
For Research Use Only. Not For Clinical Use

Online Inquiry

Services
Liposome Development Service
Liposome Contract Manufacturing
Custom Lipid Synthesis Service
One-stop Liposome Research Solution
Lipid Nanoparticle (LNP) Development Service
Products
Liposomes
Phospholipids
Modified Lipids
Other Lipids
Liposomal Kits
Support
By Modality
By Indication
Formulation
Science
Background of Liposome
Resources
Platform
Contact Us
  • Tel:  (USA)
  •  (UK)
  •  (Germany)
  • Fax:
  • Email:
Social

Creative Biolabs is a world-leading liposome provider with extensive experience in liposome preparation, custom formulation development, and characterization.

© 2024 Creative Biolabs. All rights reserved.

Inquiry
Top